Innospace's Historic Launch for South Korea's First Commercial Rocket Delayed by Weather
South Korean startup Innospace's first commercial rocket launch, Hanbit-Nano, has been delayed in Brazil due to bad weather. A successful launch would be a historic first for the country's private space sector.
South Korean space startup Innospace Co. confirmed on Monday that the launch of its Hanbit-Nano rocket, the nation's first-ever commercial orbital vehicle, has been pushed back due to unfavorable weather at its launch site in Brazil.
Rain Halts Countdown at Alcantara
The rocket was originally scheduled to lift off from the Alcantara Space Center at 3:45 p.m. local time, according to the company. However, with rain forecast for the afternoon, operators delayed the attempt until after 10 p.m. The company explained that once the rain stops, the rocket needs to be erected, a process that requires at least six hours of preparation before the final countdown can begin.
"It is difficult to forecast the exact time the rain will stop," Innospace said in a statement. "We will monitor weather conditions and announce the launch time later." This marks the third postponement since the original launch date of November 22.
High Stakes for a New Space Player
A successful mission would make Innospace the first private South Korean company to place a customer satellite into orbit, a significant milestone for the country's burgeoning space industry. The Hanbit-Nano is carrying a payload of five satellites intended for deployment into a 300-kilometer low orbit.
The two-stage vehicle is powered by a 25-ton thrust hybrid engine in its first stage, while the second stage employs a liquid methane and oxygen engine. Now, this advanced hardware is waiting on one of technology's oldest adversaries: the weather.
본 콘텐츠는 AI가 원문 기사를 기반으로 요약 및 분석한 것입니다. 정확성을 위해 노력하지만 오류가 있을 수 있으며, 원문 확인을 권장합니다.
관련 기사
미국 FDA가 노보노디스크의 비만 치료제 위고비(Wegovy)의 경구용 알약 버전을 최초로 승인했습니다. 임상시험에서 주사제와 동등한 체중 감량 효과를 입증, 비만 치료제 시장의 새로운 시대를 열 전망입니다.
미국 연방통신위원회(FCC)가 국가 안보 위협을 이유로 DJI 등 외국산 신규 드론의 수입을 전격 금지했습니다. 이번 조치의 배경과 업계 반응을 분석합니다.
AI 플랫폼 'AI 매직X'가 글쓰기, 디자인, 코딩 도구를 통합한 평생 이용권을 94% 할인된 59.97달러에 제공한다. 구독 피로감을 줄이는 올인원 AI 솔루션의 등장.
미국 FDA가 노보노디스크의 블록버스터 비만 치료제 위고비의 경구용 버전을 승인했습니다. 주 1회 주사에서 매일 먹는 알약으로 바뀌면서 일라이릴리와의 경쟁이 더욱 치열해질 전망입니다.